be_ixf;ym_202111 d_28; ct_50
Loading Events

« All Events

  • This event has passed.

COVID Associated Coagulopathy

September 1

Click HERE to Access OnDemand Recording

Click HERE to Access CME Evaluation 

NOTE: An evaluation MUST be completed in order to obtain CME credit. If you are and MD, DO, PA, or NP affiliated with one of the Beacon Health System entities, your attendance is automatically tracked. If you are not, please email bhsmededoffice@beaconhealthsystem.org to obtain a CME certificate.

COVID Associated Coagulopathy

Presented By: Mark Walsh, MD, Rashid Khan, MD and Laura Gillespie, PharmD

 

Mark Walsh, M.D., FACEP, practices Emergency Medicine and Internal Medicine at Saint Joseph’s Regional Medical Center in South Bend, Indiana.

Dr. Walsh graduated from the University of Notre Dame where he received the Rink Academic Scholarship and an athletic scholarship for track and field. He graduated from the University of Bologna, Italy School of Medicine in 1976, attending medical school in the country of his mother’s birth. Dr. Walsh completed his residency in internal medicine in 1980 at Northwestern University in Chicago. Since that time, he has practiced emergency medicine and internal medicine and has been board certified in internal medicine since 1980 and emergency medicine since 1987.

 

Rashid Khan, M.D., earned his medical degree from the Aga Khan University Medical College in Karachi, Pakistan. Dr. Khan completed his residency in internal medicine at the University of Connecticut Health Center in Farmington, Connecticut and his fellowship at the University of Maryland Medical Center in Baltimore, Maryland. Post fellowship, Dr. Khan served as faculty at the Myeloma Institute in Little Rock, Arkansas where he gained expertise in treating hematologic malignancies and autologous peripheral blood stem cell transplantation. Dr. Khan is board certified in internal medicine, medical oncology and hematology.

Dr. Khan is an active member of the American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO). He has participated in clinical and translational research, and has published several peer-reviewed articles.  He currently serves as principal investigator and participant in several clinical trials ongoing currently at Michiana Hematology Oncology.

 

Dr. Gillespie graduated from Purdue University in 2003 with a Doctor of Pharmacy degree. She worked as a Clinical Pharmacist at Memorial Hospital in South Bend for four years before joining the SJHS clinical pharmacy team in 2007. She currently serves on the following hospital committees: Antimicrobial Stewardship Program, Joint Antibiotic Subcommittee, Institutional Review Board, Pharmacy and Therapeutics Committee, Diabetes Council, Infection Prevention and CHE Trinity UCO Committee – Infection Prevention. Dr. Gillespie earned her Indiana Pharmacy Teaching Certificate from Purdue and Butler Universities, and is also an Adjunct Assistant Professor for the Advanced Practice Clerkship Programs for Purdue and Butler.

 

Accreditation Statement: The Beacon Health System of South Bend is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.

Designation Statement:  Beacon Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure:  The Speaker(s) and all planners associated with this activity do not have any potential conflict of interest.

Disclosure Statement:  As a sponsor accredited by the Indiana State Medical Association, Beacon Health System must ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs.  All faculty participating in these programs must complete a disclosure statement indicating any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program.  This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.

Commercial Support:  No commercial support was used in the planning or implementation of this CME activity.

On Demand Details: Recordings are available for credit until 9/1/2022

Questions may be directed to Jenai White at 574.647.7691 or mewhite@beaconhealthsystem.org

Details

Date:
September 1
Event Categories:
, , ,

Venue

On Demand